Abstract
A 62-year-old male with lung adenocarcinoma harboring an exon 19 deletion in the Epidermal growth factor receptor (EGFR) was treated with EGFR-tyrosin......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
